RE:RE:RE:RE:RE:RE:@88STR885I'm a little puzzled by this question of why we are here. This is an investment, not a religious of faith. Like all companies there are degrees of good and bad. And these degrees are not static... what was good 6 months ago can be questioned today. I for one like the exchanges and have learned a lot since my investment a few years ago. Both about the business itself and about the underlying science.
the recent questions being raised are perfectly legitimate:
- what is the most recent clinical progress on the various fronts. Are we at risk of being over taken by a competitor
- why is key personnel no longer with the company
- how is recruitment of new personnel going
- why is SVA not able to sustain share price value (bought deal, BoD decisions, etc...)
- what is progress on collaborations
positioning this as binary of whether we are for or against SVA misses the point and does help answer legitimate questions. Especially on the eve of AGM.
so more concretely, I am here to learn by consolidating the different view points and make up my own mind.
i do not want to be caught up in a si5uation where SVA value is destroyed by inaction and missed opportunities. In other words I don't want the next 10 years to be dead money as were the last 10. (With the exception of the Jan spike for which we are 55% off this morning)